{"name":"Seres Therapeutics, Inc.","slug":"seres-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SER-109","genericName":"SER-109","slug":"ser-109","indication":"Recurrent Clostridioides difficile infection (rCDI) in adults","status":"phase_3"}]}],"pipeline":[{"name":"SER-109","genericName":"SER-109","slug":"ser-109","phase":"phase_3","mechanism":"SER-109 is a spore-based microbiome therapeutic that restores healthy gut bacterial composition to prevent recurrent Clostridioides difficile infection.","indications":["Recurrent Clostridioides difficile infection (rCDI) in adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1iQWF2X19lME13QmttTWRSUUJqRlR2dnVfeGRsU2pOVnE5OXlqV0hhSnJaajNmYkhzVFh0T19YU2Z4TE9raHdWVDloc29KSXA5Q3FONXQ4eEtsNVBFZGxxM3lYRFlFV3J3a3NzV25xR3pCU2o1SGJXMTJoQQ?oc=5","date":"2026-04-06","type":"earnings","source":"The Business Journals","summary":"Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1 - The Business Journals","headline":"Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE54YTd6U0Z6bkhSVmR3cEFEd2lESjRaQjRpZU1paTR6T1dmQjVJTFJETkd3UXNSaGdja1NQbDFocDVaZHV0M0NyRThZT2REM1RWYldvMTJQanRiYS00NzEzVTB1Njl1bEpOQ19ST0x6cmUzTlRKZ2pOZDQtNnI?oc=5","date":"2026-03-31","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE03WE1keUg3UHhrTEdpVDlnUnNtZmtLWlkxYklQb3plcGtQdGt3bHdZUGlmbmk5U1IzNk83UFlkZEFobW1IZktOdm5rX3JmRUJSWnQ0VXlybHdxSHpXMUlUdjhobnhTMGw4ZUs2S2NR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Seres Therapeutics Inc (MCRB) - Stock Titan","headline":"If You Invested $1,000 in Seres Therapeutics Inc (MCRB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxObHBqaS1MMUVBWEwtY2tlblZpb0t5RUR4cy1DclFRMHZhcFo5WlVJNUJsUmhlU19IbEJIYlBKdWxQcWxPbFlJWk5uWVFGSzdaaEFNQzh3M3d5YUNZS3ZEUGZTLThjcVpYazA1ZV9LVnU3Vk9zUmpkVWNLS0k2TlZJNzVqNkJhRVhGM1laTExnaGEtZHRQeGNUeTB3?oc=5","date":"2026-03-09","type":"pipeline","source":"Fortune Business Insights","summary":"Microbiome Therapeutics Market Size, Share | Forecast [2034] - Fortune Business Insights","headline":"Microbiome Therapeutics Market Size, Share | Forecast [2034]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQR0RHckRIaDBzUVNGQkJMM05ZcGxPLXYxLTV0MkhNeUFIMHkyQmo2bFd3T3dqYXFwbk4yQ1RxRTJEX3AyTEpFYzZnM3U5WEdhV3dxRnBHeXhlRDJ6dDcxNTdUSXBkRnN5LUpzQlNNWDdxVGhiQ0pfck5pazFZWnFMeFZFUEktLXNLeVBhdnhicTNBbWJEdlQ5WkxIdTFhREU?oc=5","date":"2026-03-05","type":"pipeline","source":"Medical Marketing and Media","summary":"The Escalator: Seres Therapeutics, Bavarian Nordic, Moderna and more - Medical Marketing and Media","headline":"The Escalator: Seres Therapeutics, Bavarian Nordic, Moderna and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQQzVsNjZvcXFFNERYLXRITTBfekNyNDdhUzN0MjJENDdSdmUySk53OThKeF9mWjlzVVVlbmRIYktrV0w4VjJKSlNaN2VRdjNqUWZYcUpWdkdDb19RYlJTTEZBakVEaDZWeVJBNGZnby1UWXdRUnBwRjM3anBCMFZVNF9FZjJweDFLYmNQQ3JoVVBWRm5sSEpHLU96UzI?oc=5","date":"2026-02-12","type":"pipeline","source":"BioPharma Dive","summary":"Seres to lay off staff, pause top program in latest reboot - BioPharma Dive","headline":"Seres to lay off staff, pause top program in latest reboot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOTEFUbzVmLXUzZnR2T0FsOXFETkpqLW5kX3BPcVpucFo4dDhZX3JQcU5NSlU1a1JnSE9YR0hrbVA2OV9RM0dLZ1VkOWVTSFZrY2wtQkxEdU5sd1IxNWtrWlQxM1hLYUJYVHVzQzB3S0JCanZfb0JXaE5wZS1EX3BSY0RYS2pyTmZsS2VkMFIzZw?oc=5","date":"2025-11-05","type":"earnings","source":"Yahoo Finance","summary":"Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance","headline":"Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQeEh1RmJabGV4RVhEYWgwelE2bWVya21ua2p0QnlnWmk3UFg5elpVa2IzQVB6WU1CenNjeDUtMTFnUExvS29zbEQxS2R3ckJGSjdwRllLZlJFTi04eWdhc0hMOFBjN0hUSGg2c1RINHdIS0xuYzFKTDJwVHlPSWo3RUFVWThhLTNNTzdWZnhBa0N2ci1FTGRVT1dsZFB1cHM?oc=5","date":"2025-09-23","type":"trial","source":"Fierce Biotech","summary":"Seres shrinks head count by 25% to fund phase 2 study of infection biotherapeutic - Fierce Biotech","headline":"Seres shrinks head count by 25% to fund phase 2 study of infection biotherapeutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxNQnZaOHUwbWFabkV0RFAwSE4tQjNxVG5pNnFGWjFiNHlnbGI5SjBUc1pJblMydnpYN3NoV25ZcGlpdmdLM25nM0JHZVB1dnNGOGpvQjlhZ1Z3SFdFQjFPYWk3TnItRXJHeXRpTXctS1Q3RG5KVjF5MGVWX1d6eXM4RE5leUVMY0MtWUtoV0ZWeHZTb0UwZUM4bG95RkFUS25NWHdSVEwwRVF1OHNocUxiQTJvandOZ0J5aHpjVWlVRGpmYXNnbGtEcUZUQXJnN1Jmd0QxTjlvSFJKS21OY2djaVRhR2R2bnFQRHNBXzB4eDhTX3JNdnM5MWYzNk1Gc3p2WXcwakpNZlAzT3IyZzZaRjFhRG9MUGo5ZnNKODhVNWI4UXdqYV9JTTMtSDQtVEJKWHBvRm5ldDlWczFxWEdYaw?oc=5","date":"2025-09-02","type":"pipeline","source":"PR Newswire UK","summary":"Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in the 7MM during the Forecast Period (2025-2034) - PR Newswire UK","headline":"Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOaTFlRVh5QXNhZTNTam1LRmlFNTZtWUVGUDVxMTdPeUJ3empLVWx4M2dPTlVtX3pMOFkzRVczc1ZnNkNHYTdFaFJTUEp5S0c1dWFPUG1zTktzbXZnakkzXzFwWVVoTndZTE14UnNWUFNNNnBjS1BhazRZTkVMaUlMc2dWRENzVjByTVZibjNlbHJ1TWRjMVZLWDFiQS0wRDZXRU5sbjY3clpWa2lI?oc=5","date":"2025-07-29","type":"regulatory","source":"Seeking Alpha","summary":"Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough - Seeking Alpha","headline":"Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQT1Z5cXFRa0lCSElscVd4ZUdRQnB1bGJZUkVQWTJoQ3ZBYkptUnpMRER5RUtUSkp1X0Z0NmdfY0hHYVgyWXRHTHd3UWh4emtkaGdSUHlwdzRSLWJQdExNN3BETnJOWnFHSzI4SFZWSEpXbHd6Mkk2X2pZOFBDdUN6VjRLM2ZheXFheDdXREVBYlBTY3hBdU41OFJhdVc4Z1gzRGREMlZUMEYxMDRzYURfNzZJRmpkeFRnQXBXWjFQRjlKYlRsaVdnQ09abmd4YmFXb1h0cjFZWW91eXhiYnZVNUVsVFlaalNpQ2fSAe8BQVVfeXFMT1ZlNnhlcVQweHp3dkJHNjZtRlhkRWdRRC1BR0xxMUtoVkQxcVVISzVPRElMQ2EzY2FydG85RndSWGpmZmFaOVJJNGpHYUxBcVZ1eVZhaUNHN29HbVpLdWxHS09Db0x4bTQzczJZbVFkWHRvTUZTdW5nUE0yWXVTU2h5UTdBMzlHYi1uWlFRZjBVSDNoU1BiemYwWDZXaTZCYU1zQjllclBiWHk5S1BkZTBJVHpzOGdjMGc5OHRYSjRuVVUxbzBJVENSM0NFUG1tYVFUYnZxd2ZQWW5RbTQ4cXNTQzlubHNPWXBxSFoyTlU?oc=5","date":"2025-07-20","type":"pipeline","source":"simplywall.st","summary":"individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week - simplywall.st","headline":"individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQSjR6TVFlWk02b0hqT0hsMEFOUW9qVExFNnZNeW1uUXpVa0lRbS00bU5sbTBrWUhlMzNWWTE0TzBHNjM5NzAwVUxJbDZoajFWUGpYS3drTWZaS0pKMk4xZWppZEppZzFOOEVhSXVObFNwSkJQRk5uUWFydUI2RDZkRFluZmZBQ1EwcGxFLUhseFU1YUxEcWE4MlJxV1NKWEhBUDVfc085bVI1RU9I?oc=5","date":"2025-04-22","type":"pipeline","source":"Investing.com","summary":"Seres Therapeutics enacts 1-for-20 reverse stock split - Investing.com","headline":"Seres Therapeutics enacts 1-for-20 reverse stock split","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}